<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>22(Suppl 1)</volume><submitter>Behrendt CA</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>The percutaneous infrainguinal stent (PSI) register study aimed to collate all percutaneous endovascular procedures for infrainguinal peripheral arterial occlusive disease (PAOD) conducted in 74 German vascular centers between September and November 2015 (3 months). In order to obtain representative results all consecutive treatment procedures had to be submitted by the participating trial centers.&lt;h4>Material and methods&lt;/h4>This was a prospective, nonrandomized multicenter study design. All patients suffering from intermittent claudication (IC, Fontaine stage II) or critical limb ischemia (CLI, Fontaine stages III and IV) were included. Trial centers with less than 5 cases reported within the 3‑month trial period or centers that could not ensure the submission of all t</pubmed_abstract><journal>Gefasschirurgie : Zeitschrift fur vaskulare und endovaskulare Chirurgie : Organ der Deutschen und der Osterreichischen Gesellschaft fur Gefasschirurgie unter Mitarbeit der Schweizerischen Gesellschaft fur Gefasschirurgie</journal><pagination>17-27</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5306226</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Percutaneous endovascular treatment of infrainguinal PAOD: Results of the PSI register study in 74 German vascular centers.</pubmed_title><pmcid>PMC5306226</pmcid><pubmed_authors>Dus ES</pubmed_authors><pubmed_authors>Naundorf M</pubmed_authors><pubmed_authors>Kuffner H</pubmed_authors><pubmed_authors>Reimer P</pubmed_authors><pubmed_authors>Sixt S</pubmed_authors><pubmed_authors>Schmidt G</pubmed_authors><pubmed_authors>Rumenapf G</pubmed_authors><pubmed_authors>Storck M</pubmed_authors><pubmed_authors>Remig J</pubmed_authors><pubmed_authors>Ossig U</pubmed_authors><pubmed_authors>Tigges WP</pubmed_authors><pubmed_authors>Classen S</pubmed_authors><pubmed_authors>Geier B</pubmed_authors><pubmed_authors>Noppeney T</pubmed_authors><pubmed_authors>Heidemann F</pubmed_authors><pubmed_authors>Lange T</pubmed_authors><pubmed_authors>Thom KD</pubmed_authors><pubmed_authors>Huberts U</pubmed_authors><pubmed_authors>Ghoi R</pubmed_authors><pubmed_authors>Oberhuber A</pubmed_authors><pubmed_authors>Petridis C</pubmed_authors><pubmed_authors>Lauff VK</pubmed_authors><pubmed_authors>Baumhakel M</pubmed_authors><pubmed_authors>Blajan E</pubmed_authors><pubmed_authors>Gunkel W</pubmed_authors><pubmed_authors>Orend KH</pubmed_authors><pubmed_authors>Krupski-Berdien G</pubmed_authors><pubmed_authors>Wenk M</pubmed_authors><pubmed_authors>Balzer KM</pubmed_authors><pubmed_authors>Kiechle V</pubmed_authors><pubmed_authors>Burger T</pubmed_authors><pubmed_authors>Walter D</pubmed_authors><pubmed_authors>Nitschmann K</pubmed_authors><pubmed_authors>Haustein K</pubmed_authors><pubmed_authors>Kindermann M</pubmed_authors><pubmed_authors>Debus ES</pubmed_authors><pubmed_authors>Lesser T</pubmed_authors><pubmed_authors>Wenk H</pubmed_authors><pubmed_authors>Hammermuller T</pubmed_authors><pubmed_authors>Wilde J</pubmed_authors><pubmed_authors>Breuer P</pubmed_authors><pubmed_authors>Eder S</pubmed_authors><pubmed_authors>Weidenhagen R</pubmed_authors><pubmed_authors>Banafsche R</pubmed_authors><pubmed_authors>Kuhnert M</pubmed_authors><pubmed_authors>Voshage G</pubmed_authors><pubmed_authors>Hatzl J</pubmed_authors><pubmed_authors>Brune U</pubmed_authors><pubmed_authors>Grabedunkel J</pubmed_authors><pubmed_authors>Hoffmann J</pubmed_authors><pubmed_authors>Kleemann M</pubmed_authors><pubmed_authors>Pflugradt A</pubmed_authors><pubmed_authors>Teßarek J</pubmed_authors><pubmed_authors>Siggelkow M</pubmed_authors><pubmed_authors>Weis-Muller B</pubmed_authors><pubmed_authors>Dahl P</pubmed_authors><pubmed_authors>Wiedner M</pubmed_authors><pubmed_authors>Hofmann M</pubmed_authors><pubmed_authors>Schaefer T</pubmed_authors><pubmed_authors>Delgado JP</pubmed_authors><pubmed_authors>Liewald F</pubmed_authors><pubmed_authors>Schelzig H</pubmed_authors><pubmed_authors>Jacobs M</pubmed_authors><pubmed_authors>Stautner E</pubmed_authors><pubmed_authors>Dill H</pubmed_authors><pubmed_authors>Richter P</pubmed_authors><pubmed_authors>Lommel D</pubmed_authors><pubmed_authors>Kronert T</pubmed_authors><pubmed_authors>Grundmann RT</pubmed_authors><pubmed_authors>Fahrenkemper T</pubmed_authors><pubmed_authors>Wagenbreth KD</pubmed_authors><pubmed_authors>Gahlen J</pubmed_authors><pubmed_authors>Gortz H</pubmed_authors><pubmed_authors>Behrendt CA</pubmed_authors><pubmed_authors>Ockert DM</pubmed_authors><pubmed_authors>Feidicker B</pubmed_authors><pubmed_authors>Bohner H</pubmed_authors><pubmed_authors>Walluscheck KP</pubmed_authors><pubmed_authors>Seifert S</pubmed_authors><pubmed_authors>Riepe G</pubmed_authors><pubmed_authors>Schofer J</pubmed_authors><pubmed_authors>Krahl M</pubmed_authors><pubmed_authors>Coster A</pubmed_authors><pubmed_authors>Schneider M</pubmed_authors><pubmed_authors>Barbera L</pubmed_authors><pubmed_authors>Kolka P</pubmed_authors><pubmed_authors>Quellmalz U</pubmed_authors><pubmed_authors>Hader O</pubmed_authors><pubmed_authors>PSI Collaborators</pubmed_authors><pubmed_authors>Brunkwall J</pubmed_authors><pubmed_authors>Forkel J</pubmed_authors><pubmed_authors>Wittstock FT</pubmed_authors><pubmed_authors>Stehr A</pubmed_authors><pubmed_authors>Noldeke S</pubmed_authors><pubmed_authors>Teebken OE</pubmed_authors></additional><is_claimable>false</is_claimable><name>Percutaneous endovascular treatment of infrainguinal PAOD: Results of the PSI register study in 74 German vascular centers.</name><description>&lt;h4>Background&lt;/h4>The percutaneous infrainguinal stent (PSI) register study aimed to collate all percutaneous endovascular procedures for infrainguinal peripheral arterial occlusive disease (PAOD) conducted in 74 German vascular centers between September and November 2015 (3 months). In order to obtain representative results all consecutive treatment procedures had to be submitted by the participating trial centers.&lt;h4>Material and methods&lt;/h4>This was a prospective, nonrandomized multicenter study design. All patients suffering from intermittent claudication (IC, Fontaine stage II) or critical limb ischemia (CLI, Fontaine stages III and IV) were included. Trial centers with less than 5 cases reported within the 3‑month trial period or centers that could not ensure the submission of all t</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017</publication><modification>2025-04-05T15:32:41.555Z</modification><creation>2019-03-27T02:36:24Z</creation></dates><accession>S-EPMC5306226</accession><cross_references><pubmed>28715513</pubmed><doi>10.1007/s00772-016-0202-2</doi></cross_references></HashMap>